C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2004
11/18/2004	WO2004099251A2 Compositions and methods for treatment of cryptococcosis
11/18/2004	WO2004099250A1 Peptide compositions and methods of producing and using same
11/18/2004	WO2004098535A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/18/2004	WO2004085648A3 Nogo receptor binding protein
11/18/2004	WO2004080288A3 Post-translational modifications of proteins as regulatory switches
11/18/2004	WO2004078097A8 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
11/18/2004	WO2004074491A3 Expression in plants of antibodies against enterotoxigenic escherichia coli
11/18/2004	WO2004072116A3 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-1β
11/18/2004	WO2004072115A3 Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies
11/18/2004	WO2004063347A3 Epad, an oocyte specific protein
11/18/2004	WO2004061075A3 Target recognizing binding agents
11/18/2004	WO2004043353A3 Compositions and methods for treating acute myeloid leukemia
11/18/2004	WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004	WO2004002528A9 Compositions and methods for therapeutic treatment
11/18/2004	WO2003093443A3 Alcam and alcam modulators
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040231012 Transgenic rodent comprising yeast artifical chromosome which codes immunoglobulin for use as bioreactor for propagation of human antibodies
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230051 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040230034 Hybrid heterodimeric protein hormone and method of using same
11/18/2004	US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis
11/18/2004	US20040229788 Cell surface molecule mediating cell adhesion and signal transmission
11/18/2004	US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/18/2004	US20040229772 vaccines which are specific against the class of E. coli that gives rise to antibodies that cross-react with and cross-protect against the more common members of the CS4-CFA/I family
11/18/2004	US20040229339 Comprises neisseria membrane protein for use as tool in generation of vaccine to prevent infection and sepsis in infants
11/18/2004	US20040229315 nucleotide sequences that code human transient receptor potential channel polypeptides or fragments; genetic vectors, host cells, antibodies, and recombinant and synthetic methods for producing polypeptides; drug screening; medical diagnosis
11/18/2004	US20040229310 Producing high yield of monoclonal antibody in culture; for use in treatment of cell proliferative, inflammatory and nervous system disorders; immunoassay
11/18/2004	US20040229301 Tissue factor antibodies and uses thereof
11/18/2004	US20040229286 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
11/18/2004	US20040229282 Controlling and treating sepsis and thrombosis using immunoglobulin which specifically binds tissue factor and prevents binding by blood coagulation factor; immunotherapy and blood disorders
11/18/2004	US20040229281 Methods for differentiating and monitoring parathyroid and bone status related diseases
11/18/2004	US20040229280 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection
11/18/2004	US20040229279 Diagnostic drugs for autoimmune diseases
11/18/2004	US20040229277 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229243 MarA family helix-turn-helix domains and their methods of use
11/18/2004	US20040229239 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229220 Using monoclonal antibody specific to western equine encephalitis E glycoprotein to prevent, diagnose and treat viral respiratory disorder; immunotherapy; viricides
11/18/2004	US20040229218 Using immunoglobulin which binds specifically to hepatitis envelope antigens E1 and E2 to detect viral infection
11/18/2004	US20040229216 Genetically biotinylated recombinant antibody in immunofiltration assay by light addressable potentiometric sensor for identification of Venezuelan equine encephalitis virus
11/18/2004	US20040228869 Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto
11/18/2004	US20040228868 induces apoptosis in mammalian cancer cells; irinotecan; kits
11/18/2004	US20040228867 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
11/18/2004	US20040228865 Prevention and treatment of amyloidogenic disease
11/18/2004	US20040228864 polypeptides whose presence is associated with inflammatory diseases (inflammation associated antigens) and/or cancer
11/18/2004	US20040228862 Methods for treating post-surgical pain by administering a nerve growth factor antagonist and compositions containing the same
11/18/2004	US20040228861 CONTIGUOUS HEAVY AND LIGHT CHAIN SEQUENCES SPANNING COMPLEMENTARITY DETERMINING REGIONS FROM WITHIN FR1 AND/OR CDR1 THROUGH CDR3 AND/OR WITHIN FR4; cytotoxic T-lymphocyte antigen 4 (CTLA-4).
11/18/2004	US20040228860 Antibodies to a tumor-associated surface antigen for delivery of diagnostic and therapeutic agents
11/18/2004	US20040228859 inhibit binding of IGF-1 and IGF-II to IGF-IR so they act as antitumor by reducing tumor growth and/or prolonging the time of tumor progression; hybridoma cell lines; methods of preparing the compositions
11/18/2004	US20040228858 Human monoclonal antibodies to CTLA-4
11/18/2004	US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004	US20040228856 administering to the mammal a variant of a parent polypeptide comprising an Fc region; mediates antibody-dependent cell-mediated cytotoxicity (ADCC) in the presence of human effector cells more effectively than the parent polypeptide
11/18/2004	US20040228855 Method for treating symptoms of diabetes
11/18/2004	US20040228849 IKB kinase, subunits thereof, and methods of using same
11/18/2004	US20040228838 Viral interleukin-6
11/18/2004	US20040228836 cancer therapeutic agent comprising a cancer targeting molecule linked to a liver-expressed chemokine (LEC)
11/18/2004	US20040228798 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection
11/18/2004	DE10315834A1 Humane Nukleinsäuresequenzen aus Pankreaskarzinomen Nucleic acid sequences from human pancreatic cancer
11/18/2004	DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/18/2004	DE10296942T5 Therapeutische Zusammensetzung, welche die Immunitätsreaktion verändert A therapeutic composition, which changes the immunity reaction
11/18/2004	CA2766627A1 Optimized fc variants and methods for their generation
11/18/2004	CA2525243A1 Use of melanotransferrin (p97) for regulating plasminogen activation and cell migration
11/18/2004	CA2524399A1 Optimized fc variants and methods for their generation
11/18/2004	CA2524172A1 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
11/18/2004	CA2523765A1 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/17/2004	EP1477806A1 Method of determining ligand
11/17/2004	EP1477802A1 Method for selecting and producing vaccine components and vaccines based thereon
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use
11/17/2004	EP1477494A1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP1477184A2 Neospora vaccine
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476548A2 Process of cell electrofusion
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476468A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
11/17/2004	EP1476467A1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476189A1 The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
11/17/2004	EP1476186A1 Use of an inhibitor or antagonist against tissue factor
11/17/2004	EP1476185A2 Antibodies to cd40
11/17/2004	EP1476184A1 Immunogen adherence and method of making and using same
11/17/2004	EP1476180A2 Interleukin-2 mutants with reduced toxicity
11/17/2004	EP1476120A2 Treatment methods using anti-cd22 antibodies
11/17/2004	EP1476067A2 Novel compositions and methods for cancer
11/17/2004	EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004	EP1090037B1 Divalent antibody fragments conjugated to PEG
11/17/2004	EP1078266B1 HUMAN CHROMOGRANIN A (GgA) IMMUNOLOGIC ASSAY, ANTIBODIES, REAGENTS AND KITS FOR SAID ASSAY
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP0981369B1 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/17/2004	EP0942928B1 Subunit respiratory syncytial virus vaccine preparation

1 ... 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 ... 1494